# Rapid Progression of Molar Pregnancy to Choriocarcinoma With Pulmonary Metastases

**Authors:** Lucille J Wilkinson, Jared M Saifman, Pamela P Carbiener, Kelly L Molpus, Ruby A Deveras

PMC · DOI: 10.7759/cureus.83452 · Cureus · 2025-05-04

## TL;DR

A rare case of a molar pregnancy rapidly progressing to choriocarcinoma with lung metastases is presented, emphasizing the need for better management strategies for high-risk patients.

## Contribution

This case report highlights the rapid progression and extreme hCG levels in a patient with gestational trophoblastic neoplasia.

## Key findings

- The patient's hCG levels exceeded 900,000 IU/mL, indicating a high-risk molar pregnancy.
- The patient developed pulmonary metastases within two days of molar pregnancy evacuation.
- Chemotherapy led to normalization of hCG levels and tumor removal via hysterectomy.

## Abstract

Postmolar choriocarcinoma is a rare, highly malignant tumor of the placenta with characteristic histologic and clinical features. We present a case of a 31-year-old G3P2 female patient with evidence of a complete molar pregnancy indicated by symptoms of severe nausea and vomiting, a heterogenous, cystic mass on ultrasound, and human chorionic gonadotropin (hCG) levels above 900,000 IU/mL. Two days after the evacuation of the molar pregnancy, she developed symptomatic pulmonary metastases with markedly increased hCG levels and worsening symptoms. She was treated for pulmonary emboli and shortly started on EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy. However, due to persistently elevated hCG levels and rapid disease progression, she was ultimately referred to a tertiary trophoblastic disease center. She completed her chemotherapy regimen with subsequent return of her hCG levels to normal values and underwent a hysterectomy with complete removal of the tumor. While choriocarcinoma has an excellent prognosis, the accelerated progression and extreme hCG levels of this case highlight the need for further investigations into the management of molar pregnancy patients with high-risk features for gestational trophoblastic neoplasia (GTN), as well as the pathomechanism of this disease trajectory.

## Linked entities

- **Chemicals:** etoposide (PubChem CID 36462), methotrexate (PubChem CID 4112), actinomycin D (PubChem CID 457193), cyclophosphamide (PubChem CID 2907), vincristine (PubChem CID 5978)
- **Diseases:** molar pregnancy (MONDO:0006248), choriocarcinoma (MONDO:0003508)

## Full-text entities

- **Genes:** CGB5 (chorionic gonadotropin subunit beta 5) [NCBI Gene 93659] {aka CGB, HCG}
- **Diseases:** pulmonary emboli (MESH:D020766), tumor (MESH:D009369), Choriocarcinoma (MESH:D002822), Pulmonary Metastases (MESH:D009362), trophoblastic disease (MESH:D014328), placenta (MESH:D010922), Molar Pregnancy (MESH:D006828), nausea and vomiting (MESH:D020250), GTN (MESH:D031901)
- **Chemicals:** EMA/CO (MESH:C048014), actinomycin D, cyclophosphamide, vincristine (-), etoposide, (MESH:D005047), methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12133212/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12133212/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12133212/full.md

---
Source: https://tomesphere.com/paper/PMC12133212